Holen Sie sich die Stockscreener-App
6.72
1.05%
0.07
Profound Medical Corp Aktie (PROF) Neueste Nachrichten
Profound (PROF) Earnings Report: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Investor Response: The Stock Ends Down 6.07% in the Available RecordRevenue Warning Signal - Vinanet
Profound Medical (PROF) Q2 2026 Earnings Call Transcript - AOL.ca
Why Did Profound Medical Corp. (TSX:PRN) Surge 6.09% on 18 August 2026? - kalkine.ca
Why Profound Medical Corp stock surged yesterday - Wealth Awesome
Profound Medical Stock: Record Orders Meet a CFO Shake-Up - kalkine.ca
Profound Medical (TSX:PRN) Captures Focus Amid Developing Healthcare Story - Kalkine Media
Why Profound Medical Corp stock is skyrocketing today - Wealth Awesome
Profound Medical (TSX:PRN): Could The Market Be Seeing More Potential Ahead? - Kalkine Media
Profound Medical (TSE:PRN) Insider Thomas Michael Tamberrino Buys 3,755 Shares of Stock - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Profound Medical Launches TULSA-PRO Software Upgrade Targeting Up to Six Procedures Per Day - Minichart
Profound Medical Launches Enhanced TULSA-PRO Software Upgrade - TipRanks
Form 8K PROFOUND MEDICAL CORP. For: 17 August By Investing.com - Investing.com Nigeria
Profound Medical Names Interim CFO Amid Leadership Transition - TipRanks
Profound Medical (NASDAQ: PROF) targets higher TULSA throughput - Stock Titan
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’ - marketscreener.com
Some physicians report four TULSA procedures a day—what changes next? - Stock Titan
Profound Medical (PROF) shifts CFO, ex-finance chief stays on as paid adviser - Stock Titan
Profound Medical Announces Management Change - The Manila Times
Profound Medical Corp. Announces CFO Changes - marketscreener.com
Profound Medical Corp. Share Price Live Today – NASDAQ:PROF Stock Price, Chart, News, History - Upstox
Profound Medical Unveils 'Let's Huddle' Patient Advocacy Program in August 2026 Filing - Kalkine Media
Profound Medical Launches Global Prostate Patient Advocacy Community - TipRanks
Profound Medical (PROF) launches global ‘Let’s Huddle’ prostate patient community - Stock Titan
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - The Manila Times
A prostate cancer survivor helps men navigate care through Let's Huddle - Stock Titan
Understanding Momentum Shifts in (PROF) - Stock Traders Daily
Profound Medical Stock Slides 4.5% on August 11 — Is the Latest Weakness Creating a Contrarian Entry? - kalkine.ca
Why Profound Medical Corp stock is sliding today - Wealth Awesome
Profound Medical (PROF) Drops 3.5% to $7.15 as Key Support Comes into ViewTotal Put Call - dars.gov.et
Why Profound Medical Corp stock plummeted yesterday - Wealth Awesome
Profound Medical Corp (TSX:PRN) Shares Under Pressure as Investor Confidence Weakens and Healthcare Volatility Rises - kalkine.ca
Profound Medical (TSX:PRN) Just Booked Record Orders — So Why Did Revenue Look Soft? - kalkine.ca
Q2 2026 Profound Medical Corp Earnings Call Transcript - GuruFocus
Profound Medical Corp. Q2 2026 Earnings Call Summary - Yahoo Finance
Profound Medical Q2 Earnings Call Highlights - Yahoo Finance
Profound Medical Corp (PROF) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Profound Medical Corp (PROF) (Q2 2026) Earnings Call Highlights: - GuruFocus
Profound Medical (NASDAQ:PROF) Announces Earnings Results - MarketBeat
Profound Medical Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Profound Medical (PROF) Q2 Earnings Surpass Estimates - Yahoo Finance
Earnings call transcript: Profound Medical Q2 2026 revenue rises, stock slips 3.5% - Investing.com
Profound Medical Reports Second Quarter 2026 Financial Results - The Manila Times
Profound Medical Corp. 2026: Revenue $2.48M, EPS ($0.26) — 10-Q Summary - TradingView
Profound Medical (NASDAQ: PROF) boosts revenue 62% while cutting loss - Stock Titan
PROFOUND MEDICAL CORP (PRN.TO) Q2 FY2026 earnings call transcript - Yahoo Finance
About $3.1M of Profound shipments will count as Q3 revenue - Stock Titan
Profound Medical (NASDAQ: PROF) Q2 loss narrows as revenue rises - Stock Titan
Profound Medical Corp. Reiterates Earnings Guidance for the Full Year 2026 - marketscreener.com
PROF Q2 FY2026 earnings call - finance.biggo.com
Earnings To Watch: Profound Medical Corp (PROF) Q2 2026 -- GF Value Sees 226% Upside - Yahoo Finance
Profound Medical Corp expected to post a loss of 24 cents a shareEarnings Preview - TradingView
Profound Medical's TULSA Procedure Beats Robotic Prostate Surgery on Trial's Primary Safety Endpoint — Cancer-Control Data Still to Come - kalkine.ca
Profound Medical Corp. (PROF) Advances 1.79% as Shares Cling to Key Support ZoneValue Area High - dars.gov.et
Avoiding Lag: Real-Time Signals in (PROF) Movement - Stock Traders Daily
Profound Medical Corp (PROF) Valuation: PE, PB & Fair Value Analysis - TradingKey
PROF Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Market ResponseRevenue Recognition Risk - Vinanet
Profound Medical Corp (PROF) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Profound Medical Corp (PROF) Cash Flow - TradingKey
Profound Medical stock upgraded to Strong Buy on trial data, reimbursement outlook - Investing.com Canada
Robotic Radical Prostatectomy Comes Up 'Short' in CAPTAIN Trial - marketscreener.com
Profound Medical Corp. (PROF) Edges Higher as Stock Holds Key Support LevelsVanna Flow - dars.gov.et
Profound Medical Corp (PROF) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Profound Medical (TSX: PRN) Gains Momentum as TULSA-PRO Adoption, U.S. Expansion and Robotics Growth Lift Investor Confidence - kalkine.ca
Profound Medical Corp (PROF) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Profound Medical Corp (PROF) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):